Updated 84d ago
Market analysis
Analysis generated Aug 8, 2026
The market prices a 27% chance of complete cannabis rescheduling by December 31, reflecting the tight timeline for a final DEA rule after the June-July hearing concluded. While FDA-approved and state-licensed medical marijuana were rescheduled to Schedule III in April 2026, the broader rescheduling of all cannabis to Schedule III—the crux of the market bet—requires an administrative law judge decision and DEA Administrator sign-off after post-hearing briefs due August 17. Legal challenges to the April order are pending in the D.C. Circuit, and even with Trump administration urgency, finalizing the rulemaking by year-end is a tight squeeze.
As of September 9, 2026, the Polymarket odds for Weed Rescheduling are: December 31: 19%, June 30: 1%, July 31: 1%. These probabilities are derived from real-money trading and update in real time.
Weed Rescheduling is currently listed on Polymarket. Check PredictMarketCap for cross-platform availability — we surface the same event on Polymarket, Kalshi, Limitless & Predict.fun when it's listed on more than one platform.
Prediction market odds reflect the aggregate opinion of traders who risk real money on outcomes. The price of a share (e.g., 65¢) represents the market's implied probability (65%). Prices move as traders buy and sell based on new information, polls, and analysis.
